Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Management of Post-operative Respiratory Failure by Using NIV and High Velocity Nasal Insufflation (HVNI)

NCT: NCT06988111 · RECRUITING

NCT IDNCT06988111
StatusRECRUITING
Start Date2025-07-01
Completion2026-12-01

Brief Summary

Postoperative respiratory failure (PORF) remains a critical driver of morbidity, mortality, and incremental care costs in surgical populations. Traditional escalation often involves invasive mechanical ventilation, which is associated with ventilator-associated pneumonia (VAP), prolonged intensive care unit (ICU) stays, and increased resource burden.

Frequently Asked Questions

What is Management of Post-operative Respiratory Failure by Using NIV and High Velocity Nasal Insufflation (HVNI)?

Management of Post-operative Respiratory Failure by Using NIV and High Velocity Nasal Insufflation (HVNI) is a clinical trial registered under NCT06988111. Current status: RECRUITING.

What is the status of NCT06988111?

The current status of NCT06988111 (Management of Post-operative Respiratory Failure by Using NIV and High Velocity Nasal Insufflation (HVNI)) is: RECRUITING.

When did Management of Post-operative Respiratory Failure by Using NIV and High Velocity Nasal Insufflation (HVNI) start?

Management of Post-operative Respiratory Failure by Using NIV and High Velocity Nasal Insufflation (HVNI) started on 2025-07-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑